C-Reactive protein/interleukin-6 ratio as marker of the size of the uncomplicated thoracic aortic aneurysms

Interactive Cardiovascular and Thoracic Surgery

Volumn 15, Issue 5, 2012, Pages 871-877

  Artemiou, Panagiotis ^a   Charokopos, Nicholas ^b   Rouska, Efthymia ^c   Sabol, Frantisek ^d   Chrysogonidis, Ioannis ^a   Tsavdaridou, Vasiliki ^a   Paschalidis, Giannis ^e  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b Athens Euroclinic   (Greece)

^c EVANGELISMOS HOSPITAL   (Greece)

^d P J AFÁRIK UNIVERSITY   (Slovakia)

^e UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

Aneurysm; Aorta; C Reactive protein; Interleukin 6

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGE; AGED; ARTICLE; ASCENDING AORTA; ASYMPTOMATIC DISEASE; CLINICAL ARTICLE; CORRELATION ANALYSIS; DESCENDING AORTA; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPIDEMIA; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SMOKING; THORACIC AORTA ANEURYSM;

ADULT; AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, THORACIC; AORTOGRAPHY; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DISEASE PROGRESSION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84869191101     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs331     Document Type: Article

References (21)

1. Sun H, Koike T, Ichikawa T, Hatakeyama K, Shiomi M, Zhang B et al. C-Reactive protein in atherosclerotic lesions. It's origin and pathophysiological significance. Am J Pathol 2005;167:1139-48.
2. Venugopal SK, Devaraj S, Jialal I. Macrophage conditioned medium induces the expression of C-reactive protein In human aortic endothelial cells. Am J Pathol 2005;166:1265-71.
3. Reynolds GD, Vance RP. C-Reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 1987;111:265-9.
4. Smallwood L, Allcock R, van Bockxmeer F, Warrington N, Palmer LJ, Iacopetta B et al. Polymorphisms of the interleucin-6 gene promoter and abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 2008;35:31-6.
5. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
6. Lagrand WK, Visser CA, Hermens WT, Niessen HWM, Verheugt FWA, Wolbing G-J et al. C-Reactive protein as a cardiovascular risk factor: more than an epiphenomenon. Circulation 1999;100:96-102.
7. Powell JT, Muller BR, Greenhalgh RM. Acute phase proteins in patients with abdominal aortic aneurysms. J Cardiovasc Surg (Torino) 1987;28:528-30.
8. Domanovits H, Schillinger M, Mullner M, Hozelbein T, Janata K, Bayekan K et al. Acute phase reactans in patients with abdominal aortic aneurysm. Atherosclerosis 2002;163:297-302.
9. Vainas T, Lubbers T, Stassen FRM, Herngreen SB, van Dieijen-Visser MP, Bruggeman CA et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation 2003;107:1103-5.
10. Jones KG, Brull DJ, Brown LC, Sian M, Greenhalgh RM, Humphries SE et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001;103:2260-5.
11. Dawson J, Cockerill GW, Choke E, Belli A-M, Loftus I, Thompson MM. Aortic aneurysm secrete interleucin-6 into the circulation. J Vasc Surg 2007;45:350-6.
12. Rohde LEP, Arroyo LH, Rifai N, Creager MA, Libby P, Ridker PM et al. Plasma concentrations of interleucin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol 1999;19:1695-9.
13. Larson E, Vishnevskaya L, Kallin B, Granath F, Swedenborg J, Hultgren R. High frequency of thoracic aneurysms in patients with abdominal thoracic aneurysms. Ann Surg 2011;253:180-4.
14. Achneck H, Modi B, Shaw C, Rizzo J, Albornoz G, Fusco D et al. Ascending thoracic aneurysms are associated with decreased systemic atherosclerosis. Chest 2005;128:1580-6.
15. Islamoglu F, Atay Y, Can L, Kara E, Ozbaran M, Yüksel M et al. Diagnosis and treatment of concomitant aortic and coronary disease: a retrspective study and brief review. Tex Heart Inst J 1999;26:182-8.
16. Agmon Y, Khandheria BK, Meissner I, Schwartz GL, Sicks JD, Fought AJ et al. Is aortic dilatation an atherosclerosis-related process? Clinical, laboratory and transesophageal echocardiographic correlates of thoracic aortic dimensions in the population with implications for thoracic aortic aneurysm formation. J Am Coll Cardiol 2003;42:1076-83.
17. Nakashima Y, Kurozumi T, Sueishi K, Tanaka K. Dissecting aneurysm: a clinicopathologic and histopathologic study of 111 autopsied cases. Hum Pathol 1990;21:291-6.
18. Kojima S, Suwa S, Fujiwara Y, Inoue K, Mineda Y, Ohta H et al. Incidence and severity of coronary artery disease in patients with acute aortic dissection: comparison with abdominal aortic aneurysm and arteriosclerosis obliterans. J Cardiol 2001;37:165-71.
19. Sakamura K, Kubo N, Ako J, Fujiwara N, Funayama H, Ikeda N et al. Peak C-reactive protein level predicts long-term outcomes in type B acute aortic dissection. Hypertension 2010;55:422-9.
20. Jackson V, Olsson T, Kurtovic S, Folkersen L, Paloschi V, Wegsdter D et al. Matrix metalloproteinase 14 and 19 expression is associated with thoracic aortic aneurysms. J Thorac Cardiovasc Surg 2011;144:459-66.
21. Jovin IS, Duggal M, Ebisu K, Paek H, Oprea AD, Tranquilli M et al. Comparison of the effect on long-term outcomes in patients with thoracic aortic aneurysms of taking versus not taking a statin drug. Am J Cardiol 2012;109:1050-4.